These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39365887)

  • 1. Transdermal Drug Delivery Systems (TDDS): Recent Advances and Failure Modes.
    Ghaferi M; Alavi SE; Phan K; Maibach H; Mohammed Y
    Mol Pharm; 2024 Nov; 21(11):5373-5391. PubMed ID: 39365887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advancement of Medical Patch for Transdermal Drug Delivery.
    Wong WF; Ang KP; Sethi G; Looi CY
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the Road to Development of an in Vitro Permeation Test (IVPT) Model to Compare Heat Effects on Transdermal Delivery Systems: Exploratory Studies with Nicotine and Fentanyl.
    Shin SH; Ghosh P; Newman B; Hammell DC; Raney SG; Hassan HE; Stinchcomb AL
    Pharm Res; 2017 Sep; 34(9):1817-1830. PubMed ID: 28608140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system.
    Shahid N; Siddique MI; Razzaq Z; Katas H; Waqas MK; Rahman KU
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2061-2070. PubMed ID: 30081679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breaking boundaries: the advancements in transdermal delivery of antibiotics.
    Zaid Alkilani A; Hamed R; Musleh B; Sharaire Z
    Drug Deliv; 2024 Dec; 31(1):2304251. PubMed ID: 38241087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches for breaking the barriers of drug permeation through transdermal drug delivery.
    Alexander A; Dwivedi S; Ajazuddin ; Giri TK; Saraf S; Saraf S; Tripathi DK
    J Control Release; 2012 Nov; 164(1):26-40. PubMed ID: 23064010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemistry, manufacturing and controls in passive transdermal drug delivery systems.
    Goswami T; Audett J
    Ther Deliv; 2015; 6(9):1071-9. PubMed ID: 26389777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of transdermal therapeutics in perioperative care].
    Gentile A; Tran-Van D; Dardare E; Fritsch N; Benois A; Fontaine B
    Ann Fr Anesth Reanim; 2009 Apr; 28(4):311-20. PubMed ID: 19304449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical considerations for optimal transdermal drug delivery.
    Durand C; Alhammad A; Willett KC
    Am J Health Syst Pharm; 2012 Jan; 69(2):116-24. PubMed ID: 22215357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of pressure-sensitive adhesives in transdermal drug delivery systems.
    Lobo S; Sachdeva S; Goswami T
    Ther Deliv; 2016; 7(1):33-48. PubMed ID: 26652621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patch Problems? Characteristics of Transdermal Drug Delivery System Exposures Reported to the National Poison Data System.
    Thornton SL; Darracq MA
    J Med Toxicol; 2020 Jan; 16(1):33-40. PubMed ID: 31410729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A strong, silk protein-inspired tissue adhesive with an enhanced drug release mechanism for transdermal drug delivery.
    Song H; Wang L; Wu J; Liu J; Liu C; Guo J; Fang L
    Acta Biomater; 2024 Jun; 181():133-145. PubMed ID: 38641185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal drug delivery systems for fighting common viral infectious diseases.
    Wang FY; Chen Y; Huang YY; Cheng CM
    Drug Deliv Transl Res; 2021 Aug; 11(4):1498-1508. PubMed ID: 34024014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
    Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
    Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Mild Hyperthermia on Transdermal Absorption of Nicotine from Patches.
    Panda A; Sharma PK; Narasimha Murthy S
    AAPS PharmSciTech; 2019 Jan; 20(2):77. PubMed ID: 30635802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the thermally-controlled fentanyl transdermal therapy to provide constant drug delivery by physics-based digital twins.
    Bahrami F; Psikuta A; Rossi RM; Dommann A; Defraeye T
    Eur J Pharm Sci; 2024 Sep; 200():106848. PubMed ID: 38986719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin hypersensitivity reactions to transdermal therapeutic systems--still an important clinical problem.
    Jenerowicz D; Polańska A; Olek-Hrab K; Silny W
    Ginekol Pol; 2012 Jan; 83(1):46-50. PubMed ID: 22384639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanosuspension-Loaded Dissolving Microneedle Patches for Enhanced Transdermal Delivery of a Highly Lipophilic Cannabidiol.
    Cheng A; Zhang S; Meng F; Xing M; Liu H; Yang G; Gao Y
    Int J Nanomedicine; 2024; 19():4061-4079. PubMed ID: 38736651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
    Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
    Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reservoir based fentanyl transdermal drug delivery systems: effect of patch age on drug release and skin permeation.
    Prodduturi S; Smith GJ; Wokovich AM; Doub WH; Westenberger BJ; Buhse L
    Pharm Res; 2009 Jun; 26(6):1344-52. PubMed ID: 19229594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.